Comparer des méthodes

	Analyse d'impact budgétaire (AIB)	Année de vie ajustée sur la qualité (QALY)
Domaine	Économie de la santé	Économie de la santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	2005	1985
Auteur d'origine	Sullivan, Mauskopf, and colleagues (ISPOR task force)	Alan Williams (Health Economics Research Centre, Oxford University)
Type	Method	Method
Source fondatrice	Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5-14.	Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley.
Alias	BIA, financial impact assessment, budget consequence analysis	QALY, health utility measure
Apparentées	5	5
Résumé	Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a budgetary question: 'If we adopt this new drug/device, how much will it cost our health system next year?' Widely used by hospital procurement committees, insurance formularies, and government health budgets to assess financial feasibility and reimbursement decision.	A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding.